Sales & Earnings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Arrow recall benefits Utah Medical: Salt Lake City firm's neonatal sales rise 28% in Q1 as former customers of Arrow International's NeoPICC 1.9 Fr peripheral central catheter, voluntarily recalled in December, purchase Utah Medical's products as replacements, CEO Kevin Cornwell states in April 21 call (1"The Gray Sheet" Jan. 24, 2005, p. 26). In the first quarter, Utah Medical revenue totaled $6.7 mil., up 1% versus the prior-year period. The firm's obstetrics product sales slipped 6%, hampering growth....FDA v. Utah Medical: Exec notes a Department of Justice complaint seeking to halt Utah Medical sales after an FDA inspection cited persistent QSR lapses dating to 2001 is slated for a June 20 pre-trial hearing in Salt Lake City federal court (2"The Gray Sheet" Aug. 23, 2004, In Brief)...